European Portfolio  |   North American Portfolio  |   Become a Member
Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD   US46333X1081

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Most relevant news about IRONWOOD PHARMACEUTICALS,
02/23 IRONWOOD PHARMACEUTICALS : to Present at Cowen and Company 35th Annual Health Ca..
02/17 IRONWOOD PHARMACEUTICALS : Technical Briefing on Biotech Stocks -- Exelixis, Exa..
02/12 IRONWOOD PHARMACEUTICALS : reports 4Q loss
02/12 IRONWOOD PHARMACEUTICALS : Provides Fourth Quarter 2014 Investor Update
02/04 IRONWOOD PHARMACEUTICALS : Reports Positive Top-Line Data from Exploratory Phase..
01/29 IRONWOOD PHARMACEUTICALS : to Host Fourth Quarter 2014 Investor Update Call
01/05 IRONWOOD PHARMACEUTICALS : to Present at J.P. Morgan Healthcare Conference
2014 IRONWOOD PHARMACEUTICALS : Technical Report on Biotech Stocks -- MannKind, Amgen..
2014 IRONWOOD PHARMACEUTICALS : Initiates Phase IIa Clinical Study of IW-9179 in Diab..
2014 IRONWOOD PHARMACEUTICALS : Earns $15 Million Milestone from Astellas upon Initia..
2014 IRONWOOD PHARMACEUTICALS : to Present at Credit Suisse 2014 Healthcare Conferenc..
2014 IRONWOOD PHARMACEUTICALS : beats 3Q profit forecasts
2014 IRONWOOD PHARMACEUTICALS : Initiates Phase III Trial of 72 mcg Linaclotide in Ad..
2014 IRONWOOD PHARMACEUTICALS : Provides Third Quarter 2014 Investor Update
2014IRONWOOD PHARMACEUTICALS, INC. : quaterly earnings release
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
02/23 IRONWOOD PHARMACEUTICALS : to Present at Cowen and Company 35th Annual Health Ca..
02/18 IRONWOOD PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
02/17 IRONWOOD PHARMACEUTICALS : Technical Briefing on Biotech Stocks -- Exelixis, Exa..
02/12 IRONWOOD PHARMACEUTICALS : reports 4Q loss
02/12 IRONWOOD PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
02/12 IRONWOOD PHARMACEUTICALS : Provides Fourth Quarter 2014 Investor Update
02/12 IRONWOOD PHARMACEUTICALS : "Treatments for Gastrointestinal Disorders" in Patent..
02/11 IRONWOOD PHARMACEUTICALS : Patent Issued for Treatments of Gastrointestinal Diso..
02/11 IRONWOOD PHARMACEUTICALS : Reports Positive Top-Line Data from Exploratory Phase..
02/04 IRONWOOD PHARMACEUTICALS : to Host Fourth Quarter 2014 Investor Update Call
More news
Sector news Biotechnology & Medical Research - NEC
02/27 PHARMACYCLICS : Provides Clinical Update on BTK Inhibitor for Autoimmune Disease..
02/27 ISIS PHARMACEUTICALS : beats Street 4Q forecasts
02/27 ISIS PHARMACEUTICALS : Reports Positive Phase 1 Data Demonstrating ISIS-PKK Rx P..
02/27 ISIS PHARMACEUTICALS : Reports Financial Results and Highlights for 2014
02/27 QUINTILES TRANSNATIONAL : CORRECTING and REPLACING Quintiles CEO to Present at B..
02/26 QUINTILES TRANSNATIONAL : Where Pharmaceutical Companies are Heading: Complement..
Plus d'actualités du secteur Biotechnology & Medical Research - NEC
Advertisement
Chart
Duration : Period :
Ironwood Pharmaceuticals, Technical Analysis Chart | IRWD | US46333X1081 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Stay Connected :
Partners :
Copyright © 2015 Surperformance. All rights reserved.